Egon Willighagen (@egonw@social.edu.nl)

RETRACTED BOOK: Advanced Nanovaccines for Cancer Immunotherapy

This book discusses how nanomedicine can be used for better drug delivery, to overcome resistance and to boost anti-cancer immunity.

(PDF) Highly efficient genome editing using oocyte-specific z cas9 transgenic zebrafish

PDF | Since its first application, CRISPR/Cas9 rapidly becomes a routine technique to perform genome editing in a variety of biological systems. To... | Find, read and cite all the research you need on ResearchGate

Jason Shepherd on Twitter / X

I have quite a lot of thoughts on this..that won't fit in a tweet. Bottomline is that there are issues scientists in the US would love to improve - faster review, less grant writing, more stability and freedom to do risky science. The folks celebrating this doc are mostly../1 https://t.co/xlPAH9XYNC— Jason Shepherd (@JasonSynaptic) July 23, 2026

AI-designed nucleases build on nature’s design

Researchers used AI to create variants of a CRISPR-Cas12-like nuclease, some of which show increased editing activity

A new automated feedback option for authors - openRxiv

Authors who post preprints on openRxiv servers can get formal and informal feedback on their manuscripts in a number of ways. Our bioRxiv to journal (B2J) and medRxiv to journal (M2J) pipelines are linked to traditional peer review venues, enabling authors to save time by submitting directly from bioRxiv or medRxiv to any one of…

Claude for Science. Thursday, November 12, at the Niels Bohr Institute, University of Copenhagen. In September, Anthropic reported that Claude agents found a CRISPR-like enzyme system in… | Jacob Langvad Nilsson | 17 comments

Claude for Science. Thursday, November 12, at the Niels Bohr Institute, University of Copenhagen. In September, Anthropic reported that Claude agents found a CRISPR-like enzyme system in bacteriophage DNA. Earlier in the same month, another AI lab said its model had settled a question about the Navier-Stokes equations, one of the seven Millennium Prize Problems. Results like these don't come from a lucky afternoon with a chatbot. They come from years of method development, careful engineering and building on the work that came before. What has changed is how much of that work a model can now take on, and the speed of which it does it. The latest models read the literature, write and run their own code, and work through a dataset for hours without losing track. In the enzyme case, hundreds of Claude agents searched DNA data for 21 hours and flagged a pattern nobody had asked them to look for. The method still has to be sound. But a researcher with a good question can now test far more ideas in a week than before. That is what we want to show. How researchers here set up their work so that stronger models can move it forward. The evening is about how the Danish science community uses Claude to drive new research and breakthroughs. Four STEM researchers from academia and industry each show one case. What they asked Claude, how they worked, what they found, and what failed. The room is part of it. Niels Bohr lectured in Auditorium A, and in the 1930s Heisenberg and Pauli sat in the front row. We will meet in this historical auditorium and get a glimpse of frontier scientific research using Claude. ▪️ Doors open 15:30, programme 16:00 to 19:00 ▪️ Four case studies from Danish research ▪️ 50 seats on the original wooden benches ▪️ Registration by approval Thanks to Daniel Murnane for making this happen. Thanks to the Niels Bohr Institute and the University of Copenhagen for having us. To Katrin Hjorth Thordardottir for logistics. And thanks to Anthropic and the Claude Community team, Martine N., Cassie Baquero Mayes, Chiara Massironi for your continued support. Link to sign up in the first comment below. We are still confirming speakers. Which researcher in Denmark should I talk to? | 17 comments on LinkedIn

Introducing Hypothesis commenting on bioRxiv and medRxiv: an updated way to engage with preprints - openRxiv

An important part of our mission at openRxiv is to collaborate with other organizations to improve science communication and promote interoperability. Preprints are just one part of the research workflow, and we want to ensure they are effectively integrated with the tools and communities that drive scientific progress. Today, we’re excited to share about another…

Correction of scientific literature: Too little, too late!

The Coronavirus Disease 2019 (COVID-19) pandemic has highlighted the limitations of the current scientific publication system, in which serious post-publication concerns are often addressed too slowly to be effective. In this Perspective, we offer suggestions to improve academia’s willingness and ability to correct errors in an appropriate time frame.

Making sense of preprints by adding context – The Publish Your Reviews initiative - LSE Impact

Improving scientific publishing is often framed as an issue of openness and speed and less often as one of context. In this post, Ludo Waltman and Jessica Polka make the case for a more contextualised approach to open access publishing and preprinting, and introduce the Publish Your Reviews initiative. Launched today by ASAPbio, the initiative

Tobacco funded research: how even journals with bans find it hard to stem the tide of publications